Remogliflozin Etabonate
Remogliflozin Etabonate has been used in trials studying the treatment and basic science of Type 2 Diabetes Mellitus and Diabetes Mellitus, Type 2.Reference standards of Remogliflozin Etabonate API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
stdClass Object
(
[pname] => Remogliflozin Etabonate - API Standards
[catalogue_number] => PA 18 99000
[category_ids] => ,78,70,82,
[chemical_name] =>
[weight] => 522.60
[form] => C26H38N2O9
[cas] => 442201-24-3
[pslug] => 442201-24-3-remogliflozin-etabonate-api-pa1899000
[latest_product] => 0
[linkproducts] => 0
[offers_id] =>
[offers_name] =>
[offers_status] =>
[offers_start_date] =>
[offers_end_date] =>
[pageview] =>
[offers_slug] =>
[offers_product_id] =>
[offers_product_code] =>
[offers_master_id] =>
[offer_percentage] =>
[offers_product_main_cat] =>
)
Remogliflozin Etabonate - API Standards
Catalogue No.:PA 18 99000
Molecular Formula : C26H38N2O9
Molecular Weight : 522.60